SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-20-000108
Filing Date
2020-12-07
Accepted
2020-12-07 06:04:43
Documents
17
Period of Report
2020-12-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-20201205.htm   iXBRL 8-K 45391
2 EX-99.1 rare-20201205-ex99_1.htm EX-99.1 58846
3 GRAPHIC img187931544_2.jpg GRAPHIC 375412
4 GRAPHIC img187931544_3.jpg GRAPHIC 25640
5 GRAPHIC img187931544_0.jpg GRAPHIC 375412
6 GRAPHIC img187931544_1.jpg GRAPHIC 25640
  Complete submission text file 0000950170-20-000108.txt   1320838

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20201205_pre.xml EX-101.PRE 9590
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20201205.xsd EX-101.SCH 2249
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20201205_lab.xml EX-101.LAB 12931
10 EXTRACTED XBRL INSTANCE DOCUMENT rare-20201205_htm.xml XML 4522
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 201371246
SIC: 2834 Pharmaceutical Preparations